Enejoh Simon Sani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Increase of (≥) 50 CD4+ T cells/μl in post-commencement of highly active antiretroviral therapy (HAART) is acceptable as indicator of therapeutic success (TS). We therefore hypothesized that median change in CD4 count of the TS and therapeutic failure (TF) groups were comparable after 3 months; and that no associations existed between HAART outcome and(More)
  • 1